Home › Castration-Resistant Prostatic Cancer › Texas › Houston
Castration-Resistant Prostatic Cancer clinical trials in Houston, TX
6 studies for Castration-Resistant Prostatic Cancer are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 3
- Houston Metro Urology, Houston
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
RecruitingPhase 3
- MD Anderson Cancer Center, Houston
- Michael E DeBakey VA Medical Center, Houston
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 1
- NEXT Houston, Houston
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
RecruitingPhase 1
- Investigational Site Number: 401, Houston
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
RecruitingPhase 1
- Houston Methodist Hospital, Houston
A Study of MGC026 in Participants With Advanced Solid Tumors
RecruitingPhase 1
- The University of Texas MD Anderson Cancer Center, Houston
- University of Texas Health Science Center at Houston, Houston
Castration-Resistant Prostatic Cancer trials in other cities
- Los Angeles, CA8 studies
- New York City, NY7 studies
- Seattle, WA6 studies
- Boston, MA5 studies
- Philadelphia, PA4 studies
- Pittsburgh, PA4 studies
- Queens, NY4 studies
- Mountain View, CA3 studies
- Minneapolis, MN3 studies
- Baltimore, MD3 studies
- San Francisco, CA3 studies
- St. Louis, MO3 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)121 studies
- Metastatic Cancer104 studies
- Colorectal Cancer102 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia85 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer61 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.